# EDGAR Filing Document

**Accession Number:** 0001789029
**File Stem:** 0001193125-25-266977
**Filing Date:** 2025-11
**Character Count:** 28209
**Document Hash:** fc1353a005de774000f05f4592f52408
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-266977.hdr.sgml**: 20251105

**ACCESSION NUMBER**: 0001193125-25-266977

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20251105

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251105

**DATE AS OF CHANGE**: 20251105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aeva Technologies, Inc.
- **CENTRAL INDEX KEY:** 0001789029
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 843080757
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39204
- **FILM NUMBER:** 251454223

**BUSINESS ADDRESS:**
- **STREET 1:** 555 ELLIS STREET
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043
- **BUSINESS PHONE:** 6504817070

**MAIL ADDRESS:**
- **STREET 1:** 555 ELLIS STREET
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** InterPrivate Acquisition Corp.
- **DATE OF NAME CHANGE:** 20190920

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** November 05, 2025<br>

------

Aeva Technologies, Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-39204 | 84-3080757 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 555 Ellis Street |  |  |
| Mountain View**,** California |  | 94043 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (650) 481-7070<br>

Not Applicable<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common stock, par value $0.0001 per share | AEVA | The Nasdaq Stock Market LLC |
| Warrants to purchase common stock | AEVAW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 2.02 Results of Operations and Financial Condition.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On November 5, 2025, Aeva Technologies, Inc. (the "Company") issued a press release announcing financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 2.02.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information set forth in Item 2.02 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | [<u>Press Release dated November 5, 202</u>](aeva-ex99_1.htm)<u>5</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | Aeva Technologies, Inc. |
| Date: | November 5, 2025 | By:  | /s/ Saurabh Sinha |
|  |  |  | Saurabh Sinha<br>Chief Financial Officer |

---

------

## Exhibit 99.1

Exhibit 99.1

**Aeva Reports Third Quarter 2025 Results**

*Successfully Completed Top-10 Global Passenger OEM's Development Program; In Late-stage Contract Negotiations for Series Production Award* 

*Expanded Manufacturing Automation Product Line to Include Motion Sensing with Initial Sensor Orders Received*

*Bolstered Balance Sheet with $100M Investment from Apollo Global Management to Accelerate Aeva's Commercial Momentum*

**MOUNTAIN VIEW, Calif., Nov. 5, 2025 –** Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced its third quarter 2025 results.

**Key Company Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;•Successfully completed the joint development program with a Top-10 global passenger OEM and advanced to late-stage contract negotiations for a large scale series production award

&nbsp;&nbsp;&nbsp;&nbsp;•Growing interest and engagements with other major OEMs to leverage Aeva 4D LiDAR for L3 automotive applications

&nbsp;&nbsp;&nbsp;&nbsp;•Expanded deeper into manufacturing automation with Eve 1V motion sensing product line; initial orders received from multiple customers

&nbsp;&nbsp;&nbsp;&nbsp;•Brought up manufacturing line for Eve 1D with the first units produced and shipped to customers

&nbsp;&nbsp;&nbsp;&nbsp;•Apollo Global Management to invest $100 million in convertible unsecured senior notes, further positioning Aeva to accelerate commercial momentum

&nbsp;&nbsp;&nbsp;&nbsp;•On track with Daimler Truck production program with first vehicle builds completed and orders received for Atlas C Samples in 2026 to support OEM's growing vehicle fleet

&nbsp;&nbsp;&nbsp;&nbsp;•Released AevaScenes, the industry's first FMCW 4D LiDAR open dataset, to advance research and adoption of FMCW for next-generation autonomous vehicle perception

"Aeva continues to gain the trust of an expanding list of diverse customers, driven by our unified perception platform that enables next-generation capabilities across a broad range of applications," said Soroush Salehian, Co-founder and CEO at Aeva. "This includes progressing with the Top-10 global passenger OEM to final contract negotiations for a series production award. This is a pivotal time for the industry, and to further position Aeva to scale multiple programs and secure additional wins, we raised $100 million of additional capital, highlighting investor confidence in Aeva's differentiated technology and ability to execute on our strong momentum."

**Third Quarter 2025 Financial Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;•Cash, Cash Equivalents and Marketable Securities

oCash, cash equivalents and marketable securities of $48.9 million and available equity facility of $125.0 million as of September 30, 2025

&nbsp;&nbsp;&nbsp;&nbsp;•Revenue

oRevenue of $3.6 million in Q3 2025, compared to revenue of $2.3 million in Q3 2024

------

&nbsp;&nbsp;&nbsp;&nbsp;•GAAP and Non-GAAP Operating Loss\*

oGAAP operating loss of $33.2 million in Q3 2025, compared to GAAP operating loss of $37.9 million in Q3 2024

oNon-GAAP operating loss of $27.2 million in Q3 2025, compared to non-GAAP operating loss of $31.4 million in Q3 2024

&nbsp;&nbsp;&nbsp;&nbsp;•GAAP and Non-GAAP Net Income or Loss per Share\*

oGAAP basic net income per share of $1.86 and diluted net loss per share of $0.52 in Q3 2025, compared to GAAP basic and diluted net loss per share of $0.70 in Q3 2024

oNon-GAAP basic and diluted net loss per share of $0.46 in Q3 2025, compared to non-GAAP basic and diluted net loss per share of $0.55 in Q3 2024

&nbsp;&nbsp;&nbsp;&nbsp;•Shares Outstanding

oWeighted basic average shares outstanding of 57.9 million and diluted average shares outstanding of 61.1 million in Q3 2025

\*Tables reconciling GAAP to non-GAAP measures are provided at the end of this release.

**About Aeva Technologies, Inc. (Nasdaq: AEVA)**

Aeva's mission is to bring the next wave of perception to a broad range of applications from automated driving, manufacturing automation and smart infrastructure, to robotics and consumer devices. Aeva is accelerating autonomy with its groundbreaking perception platform that integrates lidar-on-chip technology, system-on-chip processing, and perception algorithms onto silicon leveraging silicon photonics. Aeva 4D LiDAR sensors uniquely detect velocity and position simultaneously, allowing automated devices like vehicles and robots to make more intelligent and safe decisions. For more information, visit www.aeva.com, or connect with us on X or LinkedIn.

*Aeva, the Aeva logo, Aeva 4D LiDAR, Aeva Atlas, Aeries, Aeva Eve, Aeva Ultra Resolution, Aeva CoreVision, and Aeva X1 are trademarks/registered trademarks of Aeva, Inc. All rights reserved. Third-party trademarks are the property of their respective owners.* 

**Forward-looking Statements**

This press release contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements in this press release include our beliefs regarding our expectations with respect to timing of product shipments, customer agreements, ability to enter new markets and investments, and our recent signed financing agreement. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including, but not limited to: (i) the fact that Aeva is an early stage company with a history of operating losses and may never achieve profitability, (ii) Aeva's limited operating history and limited history of shipping significant product volumes, (iii) the ability to implement business plans, forecasts, and other expectations and to identify and realize additional opportunities, (iv) the ability for Aeva to have its products selected for inclusion in OEM products, (v) the ability to manufacture at volumes and costs needed for commercial programs, (vi) no assurance that any of our customers will ever complete testing and validation with us or that we will receive any billings or revenues in connection with such programs or that such customers will continue such programs, (vii) the need to conclude definitive deployment or production agreements with potential customers, (viii) that any validation orders will result in larger orders, (ix) that any programs into which our products may be designed will result in significant end customer sales, (x) that any of the opportunities referenced in this press release will result in significant deployments of our products, (xi) unforeseen project delays or product issues, such as difficulties or delays in shipping, manufacturing or installation, (xii) end customer

------

acceptance of the platform, (xiii) our ability to reduce costs and unforeseen expenses and impact of global economic conditions, (xiv) acceptance of Aeva's technology in other markets, (xv) the securities purchase agreement is subject to satisfaction of closing conditions, and (xvi) other material risks and other important factors that could affect our financial results that are further described in our filings with the SEC. Please refer to our filings with the SEC, including our most recent Form 10-K and Form 10-Q. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Aeva assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Aeva does not give any assurance that it will achieve its expectations.

**Non-GAAP Information**

In addition to our financial results determined in accordance with U.S. GAAP, we present non-GAAP operating loss and non-GAAP net loss per share. "Non-GAAP operating loss" is defined as GAAP operating loss before stock-based compensation, loss on joint development agreement and litigation settlement, net. "Non-GAAP net loss per share" is defined as non-GAAP net loss divided by weighted average shares outstanding, basic and diluted. "Non-GAAP net loss" is defined as GAAP net loss before stock-based compensation, loss on joint development agreement, litigation settlement, net, fair value of share subscription liability and change in fair value of warrant liability.

We believe that non-GAAP operating loss and non-GAAP net loss per share, when taken together with the corresponding U.S. GAAP financial measures, provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our core business, results of operations, or outlook. We consider non-GAAP operating loss and non-GAAP net loss per share to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis.

However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations, including that they exclude certain expenses that are required under GAAP, which adjustments reflect the exercise of judgment by management. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures or ratios differently or may use other financial measures or ratios to evaluate their performance, all of which could reduce the usefulness of non-GAAP operating loss and non-GAAP net loss per share as tools for comparison. Reconciliations are provided at the end of this release to the most directly comparable financial measures in accordance with U.S. GAAP. Investors are encouraged to review our U.S. GAAP financial measures and not to rely on any single financial measure to evaluate our business.

**Contacts**

Media:

Michael Oldenburg

press@aeva.ai

Investors:

Andrew Fung

investors@aeva.ai

------

---

| | | |
|:---|:---|:---|
| **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** |
| **Condensed Consolidated Balance Sheet** | **Condensed Consolidated Balance Sheet** | **Condensed Consolidated Balance Sheet** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **(In thousands)** | **(In thousands)** | **(In thousands)** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| **ASSETS** |  |  |
| CURRENT ASSETS: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $45688 | $28864 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marketable securities | 3200 | 83143 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 1946 | 1187 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 4949 | 2345 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 10647 | 7761 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 66430 | 123300 |
| Operating lease right-of-use assets | 6032 | 3826 |
| Property, plant and equipment, net | 12270 | 10332 |
| Intangible assets, net | 1050 | 1725 |
| Other noncurrent assets | 7013 | 8306 |
| TOTAL ASSETS | $92795 | $147489 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $4413 | $5453 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 9786 | 5710 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued employee costs | 3573 | 5783 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease liability, current portion | 1543 | 3039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 1555 | 19174 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 20870 | 39159 |
| Lease liability, noncurrent portion | 4581 | 720 |
| Warrant liability | 33611 | 8258 |
| Other non-current liability | 515 |  |
| TOTAL LIABILITIES | 59577 | 48137 |
| STOCKHOLDERS' EQUITY: |  |  |
| Common stock | 6 | 6 |
| Additional paid-in capital | 765187 | 711160 |
| Accumulated other comprehensive income | - | 47 |
| Accumulated deficit | (731975) | (611861) |
| TOTAL STOCKHOLDERS' EQUITY | 33218 | 99352 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $92795 | $147489 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** | **AEVA TECHNOLOGIES, INC.** |
| **Condensed Consolidated Statements of Operations** | **Condensed Consolidated Statements of Operations** | **Condensed Consolidated Statements of Operations** | **Condensed Consolidated Statements of Operations** | **Condensed Consolidated Statements of Operations** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **(In thousands, except share and per share data)** | **(In thousands, except share and per share data)** | **(In thousands, except share and per share data)** | **(In thousands, except share and per share data)** | **(In thousands, except share and per share data)** |
|  | **Three Months Ended Sep 30,** | **Three Months Ended Sep 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue | $3579 | $2250 | $12458 | $6369 |
| Cost of revenue <sup>(1)</sup> | 3149 | 2971 | 14438 | 9330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit (loss) | 430 | (721) | (1980) | (2961) |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;Research and development expenses <sup>(1)</sup> | 22164 | 27116 | 66574 | 78324 |
| &nbsp;&nbsp;General and administrative expenses <sup>(1)</sup> | 9624 | 8456 | 24810 | 25530 |
| &nbsp;&nbsp;Selling and marketing expenses <sup>(1)</sup> | 1803 | 1583 | 5138 | 5818 |
| &nbsp;&nbsp;Litigation settlement, net |  |  |  | 11500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 33591 | 37155 | 96522 | 121172 |
| Operating loss | (33161) | (37876) | (98502) | (124133) |
| Interest income | 385 | 1770 | 2011 | 6327 |
| Change in fair value of warrant liability | 68524 | (1263) | (25354) | 1817 |
| Fair value gain on settlement of share subscription liability | 71647 |  | 1651 |  |
| Other income (expense), net | 166 | (5) | 273 | 19 |
| Income (loss) before income taxes | $107561 | $(37374) | $(119921) | $(115970) |
| Income tax provision | 66 | 22 | 193 | 145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $107495 | $(37396) | $(120114) | $(116115) |
| Net income (loss) per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $1.86 | $(0.70) | $(2.15) | $(2.18) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.52) | $(0.70) | $(2.15) | $(2.18) |
| Weighted-average shares used in computing net loss per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 57883326 | 53704039 | 55942977 | 53149318 |
| &nbsp;&nbsp;&nbsp;Diluted | 61087059 | 53704039 | 55942977 | 53149318 |
| <sup>(1)</sup> Includes stock-based compensation as follows: |  |  |  |  |
|  | **Three Months Ended Sep 30,** | **Three Months Ended Sep 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Cost of revenue | $51 | $42 | $114 | $208 |
| Research and development expenses | 3531 | 4261 | 9942 | 12439 |
| General and administrative expenses | 2219 | 1983 | 5944 | 3803 |
| Selling and marketing expenses | 139 | 219 | 528 | 680 |
| Total stock-based compensation expense | $5940 | $6505 | $16528 | $17130 |

---

------

**AEVA TECHNOLOGIES, INC.**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

**(In thousands)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net loss | $(120114) | $(116115) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 4053 | 4042 |
| &nbsp;&nbsp;&nbsp;Loss on joint development agreement | 3785 |  |
| &nbsp;&nbsp;&nbsp;Impairment of inventories | 493 | 883 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liability | 25354 | (1817) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 16528 | 17130 |
| &nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | 2554 | 2576 |
| &nbsp;&nbsp;&nbsp;Amortization of premium and accretion of discount on available-for-sale securities, net | (907) | (2932) |
| &nbsp;&nbsp;&nbsp;Other |  | 298 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | (759) | 53 |
| &nbsp;&nbsp;&nbsp;Inventories | (3097) | (634) |
| &nbsp;&nbsp;&nbsp;Other current assets | 3114 | (2557) |
| &nbsp;&nbsp;&nbsp;Other noncurrent assets | 301 | 317 |
| &nbsp;&nbsp;&nbsp;Accounts payable | (1511) | (563) |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 637 | 1985 |
| &nbsp;&nbsp;&nbsp;Accrued employee costs | (2210) | (1626) |
| &nbsp;&nbsp;&nbsp;Lease liability | (2394) | (2663) |
| &nbsp;&nbsp;&nbsp;Other current liabilities | (19270) | 15608 |
| &nbsp;&nbsp;&nbsp;Other non-current liability | 515 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (92928) | (86015) |
| **Cash flows from investing activities:** |  |  |
| Purchase of property, plant and equipment | (3099) | (2969) |
| Purchase of available-for-sale securities | (25548) | (62848) |
| Proceeds from maturities of available-for-sale securities | 106349 | 144108 |
| &nbsp;&nbsp;&nbsp;Net cash provided by investing activities | 77702 | 78291 |
| **Cash flows from financing activities:** |  |  |
| Proceeds from issuance of stock in private placement | 32500 |  |
| Payments of taxes withheld on net settled vesting of restricted stock units | (578) | (438) |
| Proceeds from exercise of stock options | 128 | 77 |
| &nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 32050 | (361) |
| **Net increase (decrease) in cash and cash equivalents** | 16824 | (8085) |
| **Beginning cash and cash equivalents** | 28864 | 38547 |
| **Ending cash and cash equivalents** | $45688 | $30462 |

---

------

**AEVA TECHNOLOGIES, INC.**

**Reconciliation of GAAP to Non-GAAP Operating Results**

**(Unaudited)**

**(In thousands, except share and per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Reconciliation from GAAP to non-GAAP operating loss*** |  |  |  |  |
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| GAAP operating loss | $(33161) | $(37876) | $(98502) | $(124133) |
| Stock-based compensation | 5940 | 6505 | 16528 | 17130 |
| Loss on joint development agreement |  |  | 3785 |  |
| Litigation settlement, net |  |  |  | 11500 |
| Non-GAAP operating loss | $(27221) | $(31371) | $(78189) | $(95503) |
| ***Reconciliation from GAAP to non-GAAP net loss*** |  |  |  |  |
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| GAAP net income (loss) | $107495 | $(37396) | $(120114) | $(116115) |
| Stock-based compensation | 5940 | 6505 | 16528 | 17130 |
| Loss on joint development agreement |  |  | 3785 |  |
| Change in fair value of warrant liability | (68524) | 1263 | 25354 | (1817) |
| Fair value gain on settlement of share subscription liability | (71647) |  | (1651) |  |
| Litigation settlement, net |  |  |  | 11500 |
| Non-GAAP net loss | $(26736) | $(29628) | $(76098) | $(89302) |

---

------

**AEVA TECHNOLOGIES, INC.**

**Reconciliation of GAAP to Non-GAAP Operating Results**

**(Unaudited)**

**(In thousands, except share and per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Reconciliation between GAAP and non-GAAP net income (loss) per share*** |  |  |  |  |
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Shares used in computing GAAP net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 57883326 | 53704039 | 55942977 | 53149318 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 61087059 | 53704039 | 55942977 | 53149318 |
| GAAP net income (loss) per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.86 | $(0.70) | $(2.15) | $(2.18) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.52) | $(0.70) | $(2.15) | $(2.18) |
| GAAP net income (loss) per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.86 | $(0.70) | $(2.15) | $(2.18) |
| Stock-based compensation | 0.10 | 0.13 | 0.30 | 0.31 |
| Loss on joint development agreement |  |  | 0.07 |  |
| Change in fair value of warrant liability | (1.18) | 0.02 | 0.45 | (0.03) |
| Fair value gain on settlement of share subscription liability | (1.24) |  | (0.03) | - |
| Litigation settlement, net |  |  |  | 0.22 |
| Non-GAAP net income (loss) per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic and Diluted<sup>(2)</sup> | $(0.46) | $(0.55) | $(1.36) | $(1.68) |

---

<sup>(2)</sup> As the Company was in a non-GAAP net loss position for the three months ended September 30, 2025, the Company used basic earnings per share on a GAAP basis (shares and GAAP net income (loss) per share) to reconcile to non-GAAP basic and diluted net loss per share calculations. Use of the GAAP diluted share count of 61,087,059 was not used in the reconciliation because it would result in the inclusion of additional shares that are antidilutive on non-GAAP net income (loss) per share for diluted purposes.

------